Welcome!

News Feed Item

Global MicroRNA Market Report


DUBLIN, Apr. 15, 2014 /PRNewswire/ --

Research and Markets

(

http://www.researchandmarkets.com/research/6zn3pr/global_microrna

) has announced the addition of the

"Global MicroRNA Market Report"

report to their offering.



(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The analysts forecast the Global MicroRNA market to grow at a CAGR of 17.51 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in microRNA research funding. The Global MicroRNA market has also been witnessing the discovery and development of microRNAs as biomarkers for diseases. However, the high R&D costs could pose a challenge to the growth of this market.



The report, Global MicroRNA Market Report, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers North America, Europe, and the ROW; it also covers the Global MicroRNA market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.



A biomarker is a substance or a molecular or cellular process or event that indicates a biological condition. Several research studies have confirmed that

microRNAs

have immense potential as biomarkers for a range of diseases, from cancer to cardiovascular diseases. An increasing number of vendors in the market are focusing on the discovery of microRNA biomarkers for diseases that do not as yet have defined microRNA biomarkers.


For instance, Biogen Idec Inc., a US-based biotechnology company focusing on the development of drugs for the Healthcare sector, and Regulus Therapeutics Inc., a US-based microRNA therapeutics company, have collaborated in their efforts to discover and develop microRNA biomarkers for multiple sclerosis. Thus, the Global MicroRNA market is witnessing the increasing use of microRNAs as biomarkers.

According to the report, one of the most important drivers is the increasing prevalence of diseases such as cancer, which has led to an increase in demand for microRNA-based diagnostic tests.


Key Topics Covered:

01. Executive Summary

02. Scope of the Report

03. Market Research Methodology

04. List of Abbreviations

05. Introduction

06. Market Landscape

07. Global MicroRNA Research Market

08. Global MicroRNA Market

09. Global MicroRNA Market Segmentation

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Key Vendor Analysis

20. Other Reports in this Series


Companies Mentioned:

  • Access Pharmaceuticals
  • Aegera Therapeutics Inc.
  • Affymetrix Inc.
  • Agilent Technologies
  • Alnylam Pharmaceuticals Inc.
  • Antisense Pharma GmbH
  • Aparna Biosciences Corp.
  • Applied Biological Materials Inc.
  • Arrowhead Research Corp.
  • AstraZeneca Pharmaceuticals LP
  • Asuragen Inc.
  • Benitec Biopharma Ltd.
  • BioCancell Therapeutics Inc.
  • Biogen Idec Inc.
  • CBC Comprehensive Biomarker Center GmbH
  • Clontech Laboratories Inc.
  • Dicerna Pharmaceuticals Inc.
  • EMD4Biosciences
  • Eli Lilly and Co.
  • Exiqon A/S
  • Expression Genetics Inc.
  • F. Hoffman-La Roche AG
  • Fluidigm Corp.
  • GeneCopoeia Inc.
  • GenoSensor Corp.
  • Gensignia Inc.
  • GlaxoSmithKline
  • Groove Biopharma
  • HTG Molecular Diagnostics Inc.
  • Idera Pharmaceuticals Inc.
  • Illumina Inc.
  • InteRNA Technologies B.V.
  • Isis Pharmaceuticals Inc.
  • LC Sciences Llc
  • Life Technologies Corp.
  • Merck & Co. Inc.
  • Mirna Therapeutics Inc.
  • NanoString Technologies Inc.
  • Norgen Biotek Corp.
  • Novartis AG
  • Pfizer Inc.
  • Phalanx Biotech Group
  • PhaseRx Inc.
  • Prolias Technologies Inc.
  • Qiagen N.V.
  • Quark Pharmaceuticals Inc.
  • RXi Pharmaceuticals Corp.
  • Regulus Therapeutics Inc.
  • Rosetta Genomics Ltd.
  • Sanofi U.S.
  • Santaris Pharma A/S.
  • Sarepta Therapeutics
  • Sigma-Aldrich Co. Llc
  • Silence Therapeutics Plc
  • Sirnaomics Inc.
  • Sylentis SA
  • Tacere Therapeutics Inc.
  • Tekmira Pharmaceuticals Corp.
  • Theradiag
  • Thermo Fisher Scientific Inc.
  • WaferGen Biosystems Inc.
  • miRagen Therapeutics Inc.
  • siRNAsense AS

For more information visit http://www.researchandmarkets.com/research/6zn3pr/global_microrna

Media Contact: Laura Wood , +353-1-481-1716, [email protected]



 

SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Product connectivity goes hand and hand these days with increased use of personal data. New IoT devices are becoming more personalized than ever before. In his session at 22nd Cloud Expo | DXWorld Expo, Nicolas Fierro, CEO of MIMIR Blockchain Solutions, will discuss how in order to protect your data and privacy, IoT applications need to embrace Blockchain technology for a new level of product security never before seen - or needed.
The use of containers by developers -- and now increasingly IT operators -- has grown from infatuation to deep and abiding love. But as with any long-term affair, the honeymoon soon leads to needing to live well together ... and maybe even getting some relationship help along the way. And so it goes with container orchestration and automation solutions, which are rapidly emerging as the means to maintain the bliss between rapid container adoption and broad container use among multiple cloud host...
Blockchain is a shared, secure record of exchange that establishes trust, accountability and transparency across business networks. Supported by the Linux Foundation's open source, open-standards based Hyperledger Project, Blockchain has the potential to improve regulatory compliance, reduce cost as well as advance trade. Are you curious about how Blockchain is built for business? In her session at 21st Cloud Expo, René Bostic, Technical VP of the IBM Cloud Unit in North America, discussed the b...
In his general session at 21st Cloud Expo, Greg Dumas, Calligo’s Vice President and G.M. of US operations, discussed the new Global Data Protection Regulation and how Calligo can help business stay compliant in digitally globalized world. Greg Dumas is Calligo's Vice President and G.M. of US operations. Calligo is an established service provider that provides an innovative platform for trusted cloud solutions. Calligo’s customers are typically most concerned about GDPR compliance, application p...
Imagine if you will, a retail floor so densely packed with sensors that they can pick up the movements of insects scurrying across a store aisle. Or a component of a piece of factory equipment so well-instrumented that its digital twin provides resolution down to the micrometer.
ChatOps is an emerging topic that has led to the wide availability of integrations between group chat and various other tools/platforms. Currently, HipChat is an extremely powerful collaboration platform due to the various ChatOps integrations that are available. However, DevOps automation can involve orchestration and complex workflows. In his session at @DevOpsSummit at 20th Cloud Expo, Himanshu Chhetri, CTO at Addteq, will cover practical examples and use cases such as self-provisioning infra...
Blockchain. A day doesn’t seem to go by without seeing articles and discussions about the technology. According to PwC executive Seamus Cushley, approximately $1.4B has been invested in blockchain just last year. In Gartner’s recent hype cycle for emerging technologies, blockchain is approaching the peak. It is considered by Gartner as one of the ‘Key platform-enabling technologies to track.’ While there is a lot of ‘hype vs reality’ discussions going on, there is no arguing that blockchain is b...
In his keynote at 18th Cloud Expo, Andrew Keys, Co-Founder of ConsenSys Enterprise, provided an overview of the evolution of the Internet and the Database and the future of their combination – the Blockchain. Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settle...
The cloud era has reached the stage where it is no longer a question of whether a company should migrate, but when. Enterprises have embraced the outsourcing of where their various applications are stored and who manages them, saving significant investment along the way. Plus, the cloud has become a defining competitive edge. Companies that fail to successfully adapt risk failure. The media, of course, continues to extol the virtues of the cloud, including how easy it is to get there. Migrating...
No hype cycles or predictions of a gazillion things here. IoT is here. You get it. You know your business and have great ideas for a business transformation strategy. What comes next? Time to make it happen. In his session at @ThingsExpo, Jay Mason, an Associate Partner of Analytics, IoT & Cybersecurity at M&S Consulting, presented a step-by-step plan to develop your technology implementation strategy. He also discussed the evaluation of communication standards and IoT messaging protocols, data...
You know you need the cloud, but you’re hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You’re looking at private cloud solutions based on hyperconverged infrastructure, but you’re concerned with the limits inherent in those technologies.
Coca-Cola’s Google powered digital signage system lays the groundwork for a more valuable connection between Coke and its customers. Digital signs pair software with high-resolution displays so that a message can be changed instantly based on what the operator wants to communicate or sell. In their Day 3 Keynote at 21st Cloud Expo, Greg Chambers, Global Group Director, Digital Innovation, Coca-Cola, and Vidya Nagarajan, a Senior Product Manager at Google, discussed how from store operations and ...
In his session at 21st Cloud Expo, Raju Shreewastava, founder of Big Data Trunk, provided a fun and simple way to introduce Machine Leaning to anyone and everyone. He solved a machine learning problem and demonstrated an easy way to be able to do machine learning without even coding. Raju Shreewastava is the founder of Big Data Trunk (www.BigDataTrunk.com), a Big Data Training and consulting firm with offices in the United States. He previously led the data warehouse/business intelligence and B...
"IBM is really all in on blockchain. We take a look at sort of the history of blockchain ledger technologies. It started out with bitcoin, Ethereum, and IBM evaluated these particular blockchain technologies and found they were anonymous and permissionless and that many companies were looking for permissioned blockchain," stated René Bostic, Technical VP of the IBM Cloud Unit in North America, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Conventi...
A strange thing is happening along the way to the Internet of Things, namely far too many devices to work with and manage. It has become clear that we'll need much higher efficiency user experiences that can allow us to more easily and scalably work with the thousands of devices that will soon be in each of our lives. Enter the conversational interface revolution, combining bots we can literally talk with, gesture to, and even direct with our thoughts, with embedded artificial intelligence, whic...